Our data is also in line with previous findings showing NP-specific CD8+ T cells directed against the immunodominant B7/N105 epitope were detected at high frequency in pre-SARS-CoV-2 samples, as well as in acute and convalescent COVID-19. Here, CD8A is linked to COVID-19.